Skip to main content

M Mar Mañu Pereira

Head of research Lab in rare anemia disorders - Senior researcher Scientific Director of ERN-EuroBloodNet Coordinator of the European platforms for patients registries in hematology ENROL and in rare anemia disorders RADeep

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

M Mar Mañu Pereira

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Head of research Lab in rare anemia disorders - Senior researcher Scientific Director of ERN-EuroBloodNet Coordinator of the European platforms for patients registries in hematology ENROL and in rare anemia disorders RADeep

Head of research Lab in rare anemia disorders at VHIR - 2018 - Currently
Institut de Recerca contra la Leucèmia Josep Carreras - 2016-2018
Institut d'Investigacions Biomèdiques August Pi i Sunyer / Hospital Clínic de Barcelona - 2002-2016
Dr in BioMedicine 2009

Projects

GENOMED4ALL - Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, Ferran Balbastre Ubeda, Amira Idrizovic, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 434000
Reference: GENOMED4ALL_H2020-SC1-FA-DTS-2018-20
Duration: 01/01/2021 - 30/06/2025

Erythrocytes properties and viability in dependence of flow and extra-cellular environment (EVIDENCE)

IP: M Mar Mañu Pereira
Collaborators: Amira Idrizovic
Funding agency: EUROPEAN COMMISSION
Funding: 250904.88
Reference: EVIDENCE_H2020_MSCA-ITN2019
Duration: 01/01/2020 - 31/12/2023

European Rare Blood Disorders Platform - ENROL

IP: M Mar Mañu Pereira
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 93954.6
Reference: ENROL_HP-PJ-01-2019
Duration: 01/06/2020 - 31/05/2023

European Reference Network on Rare Hematological Diseases [ERN-EuroBloodNet] [739541] - Framework Partnership Agreement

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 545439.59
Reference: EUROBLOODNET_FPA-ERN3HP2016
Duration: 01/03/2018 - 30/04/2022

Related news

The study analyzes the impact of COVID-19 on people with rare red blood cell disorders, identifying risk factors for severe forms of the disease.

The association, once again, has shown its commitment to oncological research with a donation of €19,197 to the Cancer and Hematological Diseases Group for Children at VHIR.

The prestigious journal The Lancet has published the results of this study, which is the result of more than 20 years of pre-clinical research and 7 years of patient follow-up.

Related professionals

Montse  Adell  Trape

Montse Adell Trape

General Surgery
Read more
Laia Josa Culleré

Laia Josa Culleré

Postdoctoral researcher
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Maria Garcia Carrasco

Maria Garcia Carrasco

Reconstructive Surgery of the Locomotor System
Read more
Ester Sanchez Gavilan

Ester Sanchez Gavilan

Research technician
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.